Мы используем файлы cookie.
Продолжая использовать сайт, вы даете свое согласие на работу с этими файлами.
Продолжая использовать сайт, вы даете свое согласие на работу с этими файлами.
CP-226,269
Подписчиков: 0, рейтинг: 0
Identifiers | |
---|---|
| |
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
ChemSpider |
|
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C18H19FN4 |
Molar mass | 310.376 g·mol−1 |
3D model (JSmol) | |
| |
| |
NY (what is this?) (verify) |
CP-226,269 is a drug which acts as a dopamine agonist selective for the D4 subtype, which is used for researching the role of D4receptors in the brain.
Synthesis
The piperazine used has dual use in the synthesis of ABT-724, ABT-670, Azaperone, MLS 1547 [315698-36-3], Revenast [85673-87-6], UMB38 & XH-148.
Weinreb ketone synthesis between 5-Fluoroindole-2-Carboxylic acid [399-76-8] (1) and N,O-Dimethylhydroxylamine Fb: [1117-97-1] Hcl: [6638-79-5] (2) gives the Weinreb–Nahm amide, 5-Fluoro-N-Methoxy-N-Methyl-Indole-2-Carboxamide, CID:23003585 (3). This intermediate is further reduced giving 5-Fluoro-Indole-2-Carbaldehyde [220943-23-7] (4). Reductive amination with 1-(2-Pyridyl)Piperazine [34803-66-2] (5) completed the synthesis CP-226,269 (6).